SCHEMBL22876985

SCHEMBL22876985

CC(C)c1ccc2c(n1)CCN(C(=O)CCCCN)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HTR1A P08908 2/20 0.39
DRD2 P14416 2/20 0.39
GPBAR1 Q8TDU6 1/20 0.38
CDK4 P11802 3/20 0.37
CDK2 P24941 3/20 0.37
CDK6 Q00534 3/20 0.37
CDK1 P06493 2/20 0.37
CDK7 P50613 2/20 0.37
CDK9 P50750 2/20 0.37
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18806180 0.87 CDK1 (0.44) HDAC3HDAC1HDAC10HDAC11HTR1A
SCHEMBL24199411 0.85 HDAC1 (0.48) HDAC3HDAC1HDAC10HDAC11HTR1A
SCHEMBL20203582 0.80 KDR (0.40) CDK4CDK2CDK6CDK1CDK7
SCHEMBL23733468 0.80 NPC1 (0.42) CDK4CDK2CDK6CDK1CDK7
SCHEMBL20203591 0.79 GABRG2 (0.36) CDK4CDK2CDK6CDK1CDK7
SCHEMBL20203603 0.79 CDK1 (0.46) HTR1ADRD2CDK4CDK2CDK6
SCHEMBL23733491 0.79 CYP2C19 (0.38) CDK4CDK2CDK6CDK1CDK7
SCHEMBL20203495 0.79 ACE (0.40) HPGD
SCHEMBL18819907 0.79 HSP90AA1 (0.38) CDK4ENPP2GABRG2GABRB3GABRA5
SCHEMBL20203639 0.78 FNTA (0.45) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 EP disclosed